Insurance and genetics: European policy options

European Journal of Health Law

Volumn 7, Issue 4, 2000, Pages 367-385

  McGleenan, Tony ^a   Wiesing, Urban ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENTIALITY; GENETIC DISORDER; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LEGAL ASPECT; PATIENT RIGHT; SOCIAL SECURITY;

EID: 0034484932     PISSN: 09290273     EISSN: 15718093     Source Type: Journal    
DOI: 10.1163/15718090020523269     Document Type: Article

References (68)

1. See generally, Alper, J.S., Natowicz, M. (1993) Genetic Testing and Insurance 307 British Medical Journal 1506;
2. Berry, R.M. (1996) The human genome project and the end of insurance, 7 University of Florida Journal of Law and Public Policy 205;
3. Chadwick, R., Ngwena, C. (1995) The Human Genome Project, predictive testing and insurance contracts: Ethical and legal responses, 1 Res Publica 115;
4. Cushing, T.H. (1993) Should there be genetic testing in insurance risk classification?, 60 Defense Counsel Journal 249;
5. Davis, H.R., Mitrius, J.V. (1996) Recent legislation on genetics and insurance, 37 Jurimetrics 69;
6. Dickson, D. (1993) Insurance companies fight for rights to genetic data, 365 Nature 198;
7. Gaulding, J. (1995) Race, sex and genetic discrimination in insurance: What's fair?, 80 Cornell Law Review 1646;
8. Gevers, S. (1993) Use of genetic data, employment and insurance: an international perspective, 7 Bioethics 126;
9. Glazier, A.K. (1997) Genetic predispositions, prophylactic treatments and private health insurance: Nothing is better than a good pair of genes, 23 American Journal of Law and Medicine 45;
10. Holmes, E.M. (1996) Solving the insurance/genetic fair/unfair discrimination dilemma in light of the Human Genome Project, 85 Kentucky Law Journal 503;
11. Jecker, N.S. (1993) Genetic testing and the social responsibility of private health insurance companies, 21 Journal of Law, Medicine and Ethics 109;
12. Loue, S. (1993) An epidemiological framework for the formulation of health insurance policy, 14 Journal of Legal Medicine 523;
13. McClure, H. (1995) The insurance industry's use of genetic information: legal and ethical concerns, 28 Journal of Health and Hospital Law 231;
14. Oster, H., Allen, W., Crandell, L.A., Moseley, R., Dewar, M., Nye, D., McCrary, S.V. (1993) Insurance and Genetic Testing: Where are we now?, 52 American Journal of Human Genetics 565;
15. Pokorski, R.J. (1997) Insurance underwriting in the genetic era, 60 American Journal of Human Genetics 205;
16. Rothenburg, K.H. (1995) Genetic information and health insurance: State legislative approaches, 23 Journal of Law, Medicine and Ethics 312-319;
17. Rothstein, M.A., Knoppers, B.M. (1996) Legal aspects of genetics, work and insurance in North America and Europe, 3 European Journal of Health Law 143;
18. de Wachter, M., van Luijk, A.M., Henk, J.L. Genetic information and health, life and disability insurance, In: Haker, H., Hearn, R., Steigleder K. (1993)(eds.) Ethics of human geneome analysis. Tuebingen;
19. Wortham, L. (1986) The economics of insurance classification: The sound of one invisible hand clapping, 47 Ohio State Law Journal 835. For Germany, on request of the office of technology assessment of the German Bundestag: Systamed (Insitut fuer System- und Technologieanalysen) Status und Perspektiven der Genom-Analyse (1991).
20. Sandberg, P. (1995) Genetic information and life insurance: A proposal for an ethical European policy, 40 Social Science and Medicine 1549;
21. Wortham, L. (1986) Insurance classification: Too important to be left to the actuaries, 19 University of Michigan Journal of Law Reform 349;
22. Miller, J.M. (1989) Genetic testing and insurance classification: National action can prevent discrimination based on the 'luck of the genetic draw', 93 Dickinson Law Review 729;
23. Hudson, K. (1995) Genetic discrimination and health insurance: An urgent need for reform, 270 Science 391;
24. O'Hara, S. (1993) The use of genetic testing in the health insurance industry: The creation of a biologic underclass, 22 Southwestern University Law Review 1211.
25. Beckwith, J., Alper, J.S. (1998) Reconsidering genetic anti-discrimination legislation, 26 Journal of Law, Medicine and Ethics 205.
26. See generally, Besley, T., Hall, J., Preston, I. (1996) Private Health Insurance and the State of the NHS. Institute of Fiscal Studies Report. London.
27. Friedman, K.N. (1995) Solidarity and self-governance: What Americans still could learn from Germany's national health insurance program, 13 Wisconsin International Law Journal 245.
28. Thomas, W.J. (1996) The Clinton health care reform plan: A failed dramatic presentation, 7 Stanford Law & Policy Review 83;
29. Brady, D.W., Buckley, K.M. (1995) Health care reform in the 103rd Congress: A predictable failure, 20 Journal of Health Politics, Policy and Law 447.
30. Steinmo, S, Watts, J. (1995) It's the institutions stupid! Why comprehensive national health insurance always fails in America, 20 Journal of Health Politics, Policy and Law 329;
31. Martin, C.J. (1995) Stuck in neutral: Big business and the politics of national health reform, 20 Journal of Health Politics, Policy and Law 431
32. See generally Roche, P., Glantz, L.H., Annas, G.J. (1996) The Genetic Privacy Act: A proposal for national legislation, 37 Jurimetrics.
33. See Pokorski, R.J. (1997) Insurance underwriting in the genetic era, 60 American Journal of Human Genetics 205 at 208.
34. Pokorski, R.J. (1992) Use of genetic information by private insurers: Genetic advances: The perspective of an insurance medical director 24 Journal of Insurance & Medicine 60.
35. Berry, R.M. (1996) The Human Genome Project and the end of insurance, 7 University of Florida Journal of Law and Public Policy 206.
36. McGleenan, T. (1997) Legal Regulation of Genetic Technology in the United Kingdom: Hard or Soft Options In: Muller, S., Simon, J., Westing, J.W. (eds.) Interdisciplinary Approaches to Gene Therapy: Legal, Ethical and Scientific Aspects Heidelberg: Springer Verlag;
37. Sahmer, S. (1995) Genomanalyse und Krankenversicherung, 47 Versicherungsmedizin 5.
38. Department of Trade and Industry United Kingdom Government Response to the Human Genetics Advisory Commission's Report on The Implications of Genetic Testing for Insurance. October 1998. DTI/Pub 3744/0.5k/10/98/NP
39. Black, J. (1996) Constitutionalising self-regulation, 59 Modern Law Review 24.
40. See, for example, Gibbons, L.J. (1997) No regulation, government regulation or self-regulation: Social enforcement or social contracting for governance in cyberspace, 6 Cornell Journal of Law and Public Policy 475.
41. Ogus, A. (1995) Re-thinking self-regulation, 15 Oxford Journal of Legal Studies 97.
42. Page, A. (1986) Self-regulation: The constitutional dimension, 49 Modern Law Review 141.
43. For a full analysis of regulatory theory and genetics see Black, J. (1998) Regulation as facilitation: Negotiating the genetic revolution, 61 Modern Law Review 621.
44. See, for example, Merrill, M. (1998) The sheep heard round the world: legislation vs. self-regulation of human cloning, 7 Kansas Journal of Law and Public Policy 171.
45. For a comprehensive analysis see Ogus, A. (1995) Re-thinking self-regulation, 15 Oxford Journal of Legal Studies 97.
46. Watters, L., Dugger, C. (1997) The hunt for gray whales: The dilemma of native American treaty rights and the international moratorium on whaling, 22 Columbia Journal of Environmental Law 319.
47. See for examples, Ailes, T.R. (1997) Not in my backyard: A critique of current Indiana law on land use moratoria, 72 Indiana Law Journal 775;
48. Colineaux, C.M., Galowitz, S.D. (1989) A modest proposal: The Cape Cod referendum for a moratorium on new development, 13 Harvard Environmental Law Review 559.
49. Maroney, H.M. (1993) Bioethical Catch-22: The moratorium on federal funding of fetal tissue transplantation research and the NIH revitalization amendments, 9 Journal of Contemporary Health Law and Policy 451 (1993).
50. Jones, G.K. (1990) Understanding the debate over congressionally imposed moratoria on outer continental shelf oil and gas leasing, 9 Temple Environmental Law and Technology Journal 117.
51. Smith, E.C. Supreme Court upholds state moratorium on new nuclear plants 52 University of Missouri-Kansas City Law Review 404.
52. Hewison, G.J. (1994) The legally binding nature of the moratorium of large scale high seas drift net fishing, 25 Journal of Maritime Law and Commerce 557.
53. Dworkin, R.B. (1978) Science, society and the expert town meeting: some comments on Asilomar 51 Southern California Law Review. 1471.
54. Sandberg, P. (1995) Genetic information and life insurance: A proposal for an ethical European policy 40 Social Science and Medicine 1549.
55. See generally, Leigh, T.S. (1990) Underwriting: A dying art?, 117 Journal of the Institute of Actuaries 443.
56. Colby, J.A. (1998) An analysis of genetic discrimination legislation proposed by the 105th Congress, 24 American Journal of Law and Medicine 443.
57. Carter v. Boehm (1766) 3 Burr 1905.
58. See Clarke, M. (1997) Policies and Perceptions of Insurance Oxford University Press. Oxford.
59. Epstein, R.A. (1994) The legal regulation of genetic discrimination: Old responses to new technology, 74 Boston University Law Review 1.
60. Pokorski, R.J. (1997) Insurance underwriting in the genetic era, 60 American Journal of Human Genetics 205.
61. Berry, R.M. (1996) The human genome project and the end of insurance, 7 University of Florida Journal of Law and Public Policy 205;
62. Jacobi, J.V. (1997) The ends of health insurance, 30 University of California at Davis Law Review 311.
63. See for example, Murtaugh, C.M., Kemper, P., Spillman, B.C. (1995) Risky business: Long term care insurance underwriting, 32 Inquiry 271.
64. Wortham, L. (1985) Insurance classification: Too important to be left to the actuaries, 19 University of Michigan Journal of Law Reform 349.
65. Berry, R.M. The Human Genome Project and the end of insurance, at 246.
66. Enquete-Kommission des Deutschen Bundestages, Catenhusen, W.M., Neumeister, H. (1990)(ed.) Chancen und Risiken der Gentechnologie. Dokumentation des Berichts an den Deutschen Bundestag. Frankfurt: Campus.
67. See, for example Bayer, R. (1992) HIV prevention and the two faces of partner notification, 82 American Journal of Public Health 1158;
68. Gostin, L., Hodge, J.G. (1998) Piercing the veil of secrecy in HIV/AIDS and other sexually transmitted diseases: Theories of privacy and disclosure in partner notification, 5 Duke Journal of Gender Law & Policy 9.